Existential & Meaning-Making Concerns

Not a mental disorder; may overlap adjustment disorders and DSM-5-TR Z codes (for example Z60.0, phase of life problem, or Z65.8, religious or spiritual problem)

Questions about purpose, mortality, freedom, isolation, and meaning, particularly during life transitions, terminal illness, or crises. Not a disorder but a common presenting concern. Existential, logotherapy, and meaning-centered approaches most directly address these.

Prevalence: Universal human concern; heightened during transitions and illness

Clinical Picture

Existential concerns (meaninglessness, isolation, freedom, mortality) aren't pathology. They're the inevitable consequences of being a conscious being aware of its own finitude. Therapy for existential distress isn't about symptom reduction; it's about developing a more honest and courageous relationship with the conditions of existence. Many clients present with depression or anxiety that, upon exploration, turns out to be an existential crisis: a midlife reckoning, a loss that shatters the assumptive world, a success that feels hollow, a confrontation with mortality through illness or the death of others.

Treatment Considerations

Existential therapy (Yalom, van Deurzen, Bugental) directly addresses these concerns without reducing them to symptoms. Logotherapy (Frankl) specifically targets meaning-making. ACT, while CBT-derived, engages existential themes through its emphasis on values and committed action. Psychodynamic approaches may surface existential material through the exploration of deeper fears and desires. Many clients in existential distress don't need a specific protocol; they need a therapist willing to sit with uncertainty, mortality, and meaninglessness without rushing to resolve them.


Approaches and Evidence

Of 33 associated approaches, 1 have completed assessments for this topic, 0 have source checks awaiting assessment, and 32 have neither recorded yet. Each completed assessment states its population and rationale; source checks alone do not establish effectiveness. These categories describe different findings and review stages; they are not a ranking of treatments.

Randomized studies (1)

These assessments describe randomized studies in the stated population. Randomized studies may include pilot or null findings; this label alone does not establish benefit.

Psychedelic

Psilocybin-Assisted Therapy

Griffiths / Carhart-Harris · 2016

Reviewed population: Carefully selected adults with a potentially life-threatening cancer diagnosis and anxiety/mood symptoms, receiving psilocybin with substantial preparation, monitored sessions and follow-up support.

Griffiths et al. (2016) randomized dose order in a crossover study: 56 people were assigned and 51 completed at least one session. Higher-dose treatment favored several mood and existential outcomes compared with the very-low-dose condition, including life meaning and death acceptance. After crossover at five weeks, the six-month observations lacked an unexposed comparison. The small, predominantly White, highly educated sample, expectancy and masking limits, and intensive support restrict generalization. Transient anxiety, psychological distress and blood-pressure increases occurred. This is a trial-design assessment for that supervised research context, not a guideline endorsement or evidence for all meaning-making concerns or unsupervised use.

Reviewed

Assessment not yet completed (32)

No completed assessment or source check for this topic is recorded yet.

Psychedelic

EMBARK

Brennan / Belser · 2022

Expressive

Focusing

Eugene Gendlin · 1978

Somatic

Hakomi

Ron Kurtz · 1980


Cases Featuring Associated Approaches

These teaching cases share approach links with this topic. They may illustrate a different presenting concern.


Reading This Page

Why are these approaches listed with Existential & Meaning-Making Concerns?

The catalogue associates 33 approaches and 0 frameworks with this topic. These links support learning and comparison; association alone is not a treatment recommendation or evidence of effectiveness.

How should I read the evidence assessments?

Assessments are specific to the population and scope stated on each card. They include a rationale, source links, and a review date. An overall review of an approach does not automatically apply to this condition, and a randomized-study label does not by itself mean that a study found benefit.

What does "Assessment not yet completed" mean?

A condition-specific assessment has not been recorded. Approaches with checked sources appear in a separate assessment-pending group; a checked source can support, oppose, or discuss an intervention without recommending it. Neither pending group means that no research exists or that the approach is ineffective. Frameworks are shown separately.


Sources and Review Scope

Source links and dates on assessment cards apply to the stated population and rationale. The clinical overview and prevalence text above are separate authored content; an approach's evidence label does not verify those statements. Recorded narrative notes and citations remain available on individual modality pages, with their review status identified. The bibliography provides further reading.